Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cook Islands Business Update.
Press releases published on August 6, 2025
National Healthcare Properties Reports Second Quarter 2025 Results
GlobeNewswire
·
August 6, 2025
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the “Company”), a self-managed diversified healthcare real estate investment trust focusing on seniors housing and outpatient medical facilities, …
Pacific Green Signs a Landmark Offtake Framework Agreement with Re2 Capital to Support 2GWh of BESS Projects in Australia
GlobeNewswire
·
August 6, 2025
Sydney, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Pacific Green Technologies, Inc., a global leader in battery energy storage solutions, is pleased to announce that its Australian battery storage business has signed a landmark framework agreement with Re2 Capital …
South Star Announces Closing of First Tranche of Private Placement, Extension and US$450,000 of Bridge Loans
GlobeNewswire
·
August 6, 2025
- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- South Star Battery Metals Corp. (“South Star” or the “Company”) (TSXV: STS) (OTCQB: STSBF), is pleased to …
Carriage Services Announces Second Quarter 2025 Results, Strategic Acquisitions, and Raises Full-Year 2025 Outlook
GlobeNewswire
·
August 6, 2025
HOUSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Carriage Services, Inc. (NYSE: CSV) today announced its financial results for the second quarter ended June 30, 2025. Company Highlights: GAAP net income growth of $5.5 million, or 85.7%, over the prior year …
퍼시픽 제너럴, 미국 패스트 캐주얼 브랜드 NAYA에 투자
GlobeNewswire
·
August 6, 2025
미국 뉴욕, Aug. 07, 2025 (GLOBE NEWSWIRE) -- 미국 뉴욕에 본사를 둔 사모펀드 운용사 퍼시픽 제너럴(Pacific General)이 지중해/중동식 패스트 캐주얼 레스토랑 브랜드인 NAYA (Naya Group LLC)에 투자했다고 발표했다. NAYA는 현재 미국 내 6개 주에서 35개의 직영 매장을 운영하며 빠르게 성장 중인 브랜드이다. 본 투자는 뉴욕과 런던에 기반을 둔 사모펀드 운용사 TriSpan(USA), LLC의 …
Quick Custom Intelligence Partners with ComOps to Offer Secure, Scalable Off-Site Human Player-Development Services for Casinos
GlobeNewswire
·
August 6, 2025
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), the global leader in AI-driven casino analytics, today announced a strategic partnership with ComOps, a hospitality performance partner delivering support-as-a-service solutions …
Sable Offshore Corp. (SOC) Hit with Lawsuit Over Alleged Misleading Statements on California Oil Restart – Hagens Berman
GlobeNewswire
·
August 6, 2025
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sable Offshore Corp. (NYSE: SOC) is now at the center of a securities class-action lawsuit, alleging that the company misled investors to inflate its stock price just before a major secondary offering. The …
ROSEN, LEADING INVESTOR COUNSEL, Encourages Neogen Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NEOG
GlobeNewswire
·
August 6, 2025
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”), of the …
PEPG DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages PepGen Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 8 Deadline in Securities Class Action – PEPG
GlobeNewswire
·
August 6, 2025
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”), of the …
Lockheed Martin (LMT) Faces Investor Scrutiny Over Company’s Disclosures About Aeronautics and RMS Segments’ Performance, Securities Class Action Pending -- Hagens Berman
GlobeNewswire
·
August 6, 2025
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Khan v. Lockheed Martin Corporation, et al., No. 1:25-cv-06197 (S.D.N.Y.) has been filed and seeks to represent investors who purchased or otherwise acquired Lockheed …
South Bow Reports Second-quarter 2025 Results and Declares Dividend
GlobeNewswire
·
August 6, 2025
CALGARY, Alberta, Aug. 06, 2025 (GLOBE NEWSWIRE) -- South Bow Corp. (TSX …
Explore Exclusive Las Vegas Country Club Homes For Sale with Las Vegas Homes By Leslie - RE/MAX United Realtor
GlobeNewswire
·
August 6, 2025
Las Vegas, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Las Vegas Homes By Leslie - RE/MAX United Realtor, a top real estate team in Las Vegas, has introduced significant updates to its services. The company is committed to helping both longtime residents and …
North American Construction Group Ltd. Announces $2.0 Billion, Five-Year Contract in Queensland, Australia
GlobeNewswire
·
August 6, 2025
ACHESON, Alberta, Aug. 06, 2025 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. (“NACG” or “the Company”) (TSX:NOA.TO/NYSE:NOA) today announced that the MacKellar Group (“MacKellar”), a wholly owned subsidiary of NACG, has been awarded an …
Aura Announces Exercise of the Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
August 6, 2025
ROAD TOWN, British Virgin Islands, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (Nasdaq: AUGO) (TSX: ORA) (B3: AURA33) (“Aura” or the “Company”) today announced that it has closed the sale of 897,134 common shares as a result of the partial …
Sarepta Therapeutics (SRPT) Declines Again On EMA Recommendation to Refuse ELEVIDYS Marketing Authorization, Securities Class Action Pending – Hagens Berman
GlobeNewswire
·
August 6, 2025
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- On July 24, 2025, the European Medicines Agency (“EMA”) recommended the refusal of the marketing authorization for ELEVIDYS, Sarepta’s medication intended for the treatment of Duchenne muscular dystrophy. …
First Quantum Minerals Announces Cash Tender Offer To Purchase Its Outstanding 9.375% Senior Secured Second Lien Notes Due 2029 In A Maximum Aggregate Principal Amount Of Up To $250 Million
GlobeNewswire
·
August 6, 2025
(In United States dollars, except where noted otherwise) TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- First Quantum Minerals Ltd. (“First Quantum” or the “Company”) (TSX: FM) today announced that it has commenced an offer to purchase for cash (the “Tender …
Extendicare Announces 2025 Second Quarter Results
GlobeNewswire
·
August 6, 2025
MARKHAM, Ontario, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2025. Second Quarter 2025 Highlights Adjusted EBITDA(1), excluding out-of- …
SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire
·
August 6, 2025
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that …
First Quantum Minerals Announces Extension of the Expiration Date, Guaranteed Delivery Date and Settlement Date of Cash Tender Offer to Purchase Any and All of Its Outstanding 6.875% Senior Notes Due 2027
GlobeNewswire
·
August 6, 2025
(In United States dollars, except where noted otherwise) TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- First Quantum Minerals Ltd. (“First Quantum” or the “Company”) (TSX: FM), in connection with the offer to purchase for cash (the “Tender Offer”) any and all …
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman
GlobeNewswire
·
August 6, 2025
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- When, on May 27, 2025, Rocket Pharmaceuticals (NASDAQ: RCKT) revealed that the FDA put a clinical hold on its Phase 2 pivotal trial for RP-A501, an experimental therapy intended to treat patients with a rare …